More importantly, we showed the efficacy of baicalein in reducing airway inflammation and airway remodeling in an OVA-induced asthma mouse model and verified the involvement of the VEGF and EGFR signaling pathways in the therapeutic effect of baicalein. The gene discussed is VEGFA; the disease is asthma.